Table 2 The pathways overlapped in results of GSVA and GSEA
From: Cerebrospinal fluid cells immune landscape in multiple sclerosis
| Pathway | GSVA | GSEA | ||
|---|---|---|---|---|
| logFC | Adj. P. val | NES | p-val | |
| KEGG_UBIQUITIN_MEDIATED_PROTEOLYSIS | 0.257353 | 0.000123 | 1.601199 | 0.018443 |
| KEGG_PRIMARY_IMMUNODEFICIENCY | 0.256664 | 0.014024 | 1.54737 | 0.032389 |
| KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS | − 0.30003 | 0.014921 | − 1.46851 | 0.039293 |
| KEGG_LYSOSOME | − 0.26996 | 0.00536 | − 1.5659 | 0.038536 |
|
KEGG_GLYCOSAMINOGLYCAN_ DEGRADATION | − 0.32315 | 0.000742 | − 1.68337 | 0.005941 |
| KEGG_COMPLEMENT_AND_COAGULATION_ CASCADES | − 0.36335 | 1.77E−06 | − 1.54136 | 0.005917 |
|
KEGG_ARRHYTHMOGENIC_RIGHT_ VENTRICULAR_CARDIOMYOPATHY_ARVC | − 0.20114 | 0.003886 | − 1.47921 | 0.008163 |